US$ 20.68
oral glp 1 inhibitors GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Oral Small-Molecule GLP-1 Receptor Agonists:
Description
Weight Loss, Done the Right Way

Biochem Biophys Res Commun 466 , 3339, (2015)

By the time the timer goes off, you are ready

Proposals should be made to the corresponding author and will be reviewed by the Birmingham Clinical Trials Unit Data Sharing Committee in discussion with the Chief Investigator
